-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the fourth quarter of 2021, Dow's team once again achieved year-on-year revenue and profit growth in all operating segments
.
Strong underlying demand and continued rigour in business operations have allowed Dow to overcome supply and logistics constraints and rising raw material and energy costs
.
The financial report shows that in the fourth quarter of last year, Dow’s net sales were $14.
4 billion, a year-on-year increase of 34%
.
Growth was achieved across all operating segments, business segments and regions
.
Dow Chairman and Chief Executive Officer Jim Fitlin said: "The fourth quarter results capped Dow's record 2021.
Dow achieved $55 billion in full-year sales and 95 $7.
1 billion in operating EBIT
.
Looking ahead to 2022, Fitlin said: "As industrial production continues to grow and consumer spending continues to increase, end-market demand will continue to be strong
.
After a year of supply constraints and logistical challenges posed by the COVID-19 pandemic, Dow is working to normalize operating rates, inventory and service levels
.